Newsroom

Niedersächsischer Ministerpräsident Stephan Weil und Minister Björn Thümler besuchen das Helmholtz-Zentrum für Infektionsforschung.

News

A distinguished visitor to the Helmholtz Centre for Infection Research: The Prime Minister of Lower Saxony Stephan Weil and Lower Saxony’s Minister of Science and Culture Björn Thümler visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig today. The focus of the visit was on current challenges and innovative solutions, especially in the fight against SARS-CoV-2 and the future development of infection research in Lower Saxony.

08.05.2020

HZI Campus

Cas12a-Nukleasen sind leistungsstarke Werkzeuge zur Genombearbeitung, erfordern jedoch ein PAM neben jeder ausgewählten Zielsequenz. Beisels Forschungsgruppe fand heraus, dass zwei sehr ähnliche Cas12a-Nukleasen unterschiedliche PAMs erkennen können.

News

CRISPR technologies are revolutionary genome-editing tools that rely on molecular scissors called Cas nucleases to cut DNA. While these scissors can be programmed to cut virtually any sequence, that target must be flanked by a special sequence called a PAM (Protospacer Adjacent Motif). The PAM sequence is up to six nucleotides in length and can vary widely between Cas nucleases. To allow all sites of the genome to be targeted with CRISPR technologies, there is an ongoing push to collect nucleases that cover all possible PAMs. In a current study published in Nucleic Acids Research, researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg characterized technologically important Cas nucleases to determine how to expand the spectrum of target sequences. The HIRI is a joint institution of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Julius Maximilian University of Würzburg.

07.05.2020

HIRI

Der Virologe Luka Cicin-Sain erforscht SARS-CoV-2-neutralisierende Antikörper, die von der Technischen Universität Braunschweig und YUMAB isoliert wurden.

News

Neutralizing antibodies are the interceptors of our immune system. They bind precisely to pathogens and prevent them from entering our cells. After an infection, the immune system needs about two weeks to produce mature antibodies. In severe cases of Covid-19, the body's immune reaction often comes too late for the patient. One option for acute treatment would therefore be to administer antibodies to the patients that are immediately effective. Recent results of the CORAT Consortia, especially from the Helmholtz Centre for Infection Research (HZI) in cooperation with the Technische Universität Braunschweig and the company YUMAB, have led to a breakthrough in the development of fully human antibodies for immune therapies.

07.05.2020

HZI Campus

Illustration des Coronavirus SARS-CoV-2.

News

29.04.2020

How susceptible are small children to the new coronavirus? Tests on 500 LöwenKIDS are underway.

News

Currently, little is known about children and their susceptibility to the new coronavirus. It has been observed that young children have rarely presented with COVID-19 up to now. No specific investigations have been conducted as to how many children have already contracted the virus and overcome the infection without any remarkable symptoms. In a DZIF project, scientists now intend to investigate this with the help of “LoewenKIDS”.

28.04.2020

HZI Campus

TWINCORE

In der weltweit größten Substanz-Repurposing-Bank „ReFrame“ suchen Wissenschaftler nach Medikamenten gegen COVID-19.

News

Innovations based on proven active ingredients, new indications for established drugs – the principle of repurposing has often led to success in medicine. This is why it is also used against SARS-CoV-2: In order to quickly find a drug to treat COVID-19, this international research network is searching for substances that act against SARS-CoV-2 in the world's largest substance repurposing bank "ReFrame". The collection comprises around 14,000 approved drugs as well as active ingredients for which extensive safety data are already available with regard to their use in humans. Several laboratories in the USA, four in the UK and one each in China and Germany are involved in the search. "ReFrame" was established by Scripps Research, California, in 2018 with the support of the Bill & Melinda Gates Foundation.

24.04.2020

TWINCORE

Back to the first page
...
50
51
52
53
...
131

HZI in the media

before and we just didn’t notice?” asks Fabian Leendertz, director of the Helmholtz Institute for One Health. He points out that wildlife

25.06.2025

Resurgence

... Samonellen liegen unter Schwarzlicht im Labor des Helmholtz-Zentrums in Braunschweig. Foto: Peter Steffen/dpa ...

23.06.2025

Kurier

Slevogt from the MHH and the Helmholtz Centre for Infection Research (“Helmholtz-Zentrum für Infektionsforschung“; HZI). An application for

23.06.2025

Trading View

... der Universität des Saarlandes , des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS) und internationalen Teams ...

19.06.2025

CHIP

Forschende am Helmholtz-Zentrum für Infektionsforschung in Braunschweig (Niedersachsen) arbeiten an einer neuer Impfstoff-Technologie, die

18.06.2025

17:30 SAT.1 REGIONAL

... machen

Die Studie der Wissenschaftler des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig will daher vor ...

18.06.2025

Cityblick 24

including Dr. Max Kellner and Prof.‌ Josef Penninger of the⁢ Helmholtz Center for Infection Research (HZI), explored this ‌resilience.They

17.06.2025

Newsdirectory3

the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Chair of Microbiology of the Julius-Maximilians-Universität Würzburg

17.06.2025

Phys.org

Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) ...

17.06.2025

DeutschesGesundheitsPortal

Register now for the HZI-Newsletter

and stay up to date!

Email address

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.

Please enter here the word as displayed in the picture. This is to prevent spamming.*

If you can't read the word, click here.